Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Return on Sales (2021 - 2025)

Historic Return on Sales for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 0.29%.

  • MDxHealth's Return on Sales rose 1600.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year increase of 4900.0%. This contributed to the annual value of 0.57% for FY2024, which is 400.0% up from last year.
  • Per MDxHealth's latest filing, its Return on Sales stood at 0.29% for Q3 2025, which was up 1600.0% from 0.0% recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Return on Sales peaked at 2969.6% during Q2 2022, and registered a low of 1.39% during Q3 2021.
  • For the 5-year period, MDxHealth's Return on Sales averaged around 174.02%, with its median value being 0.52% (2024).
  • Examining YoY changes over the last 5 years, MDxHealth's Return on Sales showed a top increase of 8000bps in 2023 and a maximum decrease of -29702300bps in 2023.
  • Quarter analysis of 5 years shows MDxHealth's Return on Sales stood at 1.34% in 2021, then increased by 30bps to 0.95% in 2022, then surged by 42bps to 0.55% in 2023, then skyrocketed by 51bps to 0.27% in 2024, then dropped by -7bps to 0.29% in 2025.
  • Its Return on Sales stands at 0.29% for Q3 2025, versus 0.0% for Q2 2025 and 0.37% for Q1 2025.